Avanti Polar Lipids, LLC
Alabaster, AL
- UEI
- J74LJLHJ97C5
- CAGE
- 0B375
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- 700 Industrial Park Dr, Alabaster, AL 35007, USA
- Website
- avantilipids.com
- Founded
- 1969
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$268,256 |
| FY2024 | $547,976 |
| FY2023 | -$1,763 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel reagents to bypass limitations of existing coagulation assays | National Institutes of Health | $241,675 | |
| Organized lipid matrix: fatty acids and choline in CF | National Institutes of Health | $2,682,829 |
Similar vendors
About the company
Avanti Polar Lipids, LLC is a foreign-owned, for-profit manufacturer of biological reagents located in Alabaster, Alabama. Registered in SAM.gov since March 9, 2000, the company specializes in producing high-quality lipids, detergents, and other specialized chemical materials primarily for scientific and medical research purposes. The company has established itself as a critical supplier to federal research institutions, particularly within the National Institutes of Health (NIH) ecosystem, providing essential materials that support advanced medical and scientific research initiatives.
The federal contract awards demonstrate Avanti Polar Lipids' expertise in supplying specialized biological and chemical materials across multiple research domains. Their contract awards include specific procurement for COVID-19 research biological reagents, specialized chemicals like 3D-PHAD, cholesterol, and enantiomeric 25-hydroxycholesterol. Notably, they have secured contracts with agencies including the National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences, and the Defense Health Agency. The company has manufactured specific pharmaceutical substances like the Army Liposome Formulation 55 (ALF55) for the Walter Reed Army Institute of Research, highlighting their capability to produce complex biological materials. None of their contract awards have been set aside for specific socioeconomic programs, indicating they compete in the open federal marketplace.
Avanti Polar Lipids has secured a significant Blanket Purchase Agreement (BPA) with the Office of Logistics and Acquisition Operations at the U.S. Department of Health and Human Services, valued at $1 billion with a performance period through December 31, 2025. This single-award BPA provides HHS/NIH with a streamlined procurement mechanism to acquire chemicals and reagents for operational and maintenance purposes. The BPA allows for flexible, cost-effective procurement of essential chemicals and reagents as research needs evolve, enabling NIH laboratories and clinical programs to maintain a reliable supply of critical materials. This agreement underscores the company's strategic importance in supporting federal research infrastructure by providing a consistent, high-quality source of specialized biological and chemical materials across multiple research domains.
Quick answers
Is Avanti Polar Lipids, LLC registered in SAM.gov?
Yes. Avanti Polar Lipids, LLC's SAM.gov registration is active through March 24, 2027.
How much has Avanti Polar Lipids, LLC received in federal contracts?
Federal contracts obligated $277,957 to Avanti Polar Lipids, LLC in fiscal years 2023 through 2027.
What is Avanti Polar Lipids, LLC's most recent federal award?
Avanti Polar Lipids, LLC's most recent federal contract award is Avanti polar lipids:1109394 [24-002141] (75N98024P02349), from Office of Logisitics and Acquisition Operations (NIH), on July 16, 2024.
On GovTribe
See Avanti Polar Lipids, LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors